NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo hopes to boost lung cancer treatment
Disease control Recruiting nowThis study tests whether adding an experimental drug called binimetinib to the immunotherapy pembrolizumab can help people with advanced non-small cell lung cancer. About 40 participants will receive the combination to find the safest dose and see if tumors shrink. The goal is to…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New pill targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug called DO-2 in adults with advanced solid tumors (like lung or kidney cancer) that have not responded to standard treatments. The main goal is to check safety and find the right dose. About 55 people will take part, and researchers wil…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Liver zapping may supercharge lung cancer treatment
Disease control Recruiting nowThis study tests whether adding targeted radiation to liver tumors can make standard immunotherapy work better for people with advanced non-small cell lung cancer (NSCLC) that has spread to the liver. About 68 adults with stage IV NSCLC will receive either standard drug therapy a…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New hope for tough lung cancer: experimental drug takes on standard chemo
Disease control Recruiting nowThis study tests whether a new drug called PF-08046054 works better than the standard chemo docetaxel for people with advanced non-small cell lung cancer that has PD-L1 protein and has stopped responding to other treatments. About 680 adults will be randomly assigned to get one o…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
Step up recovery: telecoaching aims to get lung cancer patients moving after surgery
Symptom relief Recruiting nowThis study tests a 12-week home-based coaching program for people with early-stage lung cancer who have had surgery. Participants wear a Fitbit and get personalized step goals and coach calls to help them increase daily walking. The goal is to see if this support helps patients b…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 16, 2026 12:53 UTC